Published in Blood Weekly, May 18th, 2000
N. Basara and colleagues in Germany studied the effectiveness of prophylactic MMF, already shown to be effective for kidney and heart transplant recipients, on 13 patients receiving transplants from human leukocyte antigen (HLA)-mismatched donors, according to their report ("Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients," Clin Transplant,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.